NewswireToday - /newswire/ - Delhi, India, 07/28/2009 - The report analyzes the molecular diagnostics segment of IVD industry. The study explores the potential business opportunities. Further, factors that are driving the growth of the industry have been assessed.

Molecular diagnostics or the analysis of DNA and RNA at the molecular level - is a fast-growing market, driven by the growing understanding of the human genome. Although a small part of the In-Vitro Diagnostics (IVD) market, molecular diagnostics market is one of the two growth drivers of the IVD industry.

In the decision making process of healthcare experts, diagnostics tests have a major influence. Diagnostics tests are a very small percentage cost of medical expenditures but generally accounts for 60-70% of all treatment decisions. And with the advent of molecular diagnostics, there is a growing focus on diagnostics for early detection of diseases.

Molecular diagnostics holds immense business potential as it is based on the intention of identifying viruses and infectious diseases more accurately at an earlier stage than currently possible. Molecular diagnostics has also emerged as a potential business opportunity as diagnostics businesses generally fetch higher returns of investment than pharmaceutical and other biotech businesses.

The molecular diagnostics industry is growing on the path of continuous innovation and changing technological base and this is creating new opportunities and applications. The major factors that will drive the growth of this industry includes the increasing incidences of various chronic diseases, increasing number of cases of hepatitis B and tuberculosis and the availability of various molecular diagnostics tests. Molecular diagnostics or MDx is the fastest growing segment of the IVD market, also because of the innovation in the industry resulting in the advent of new technologies for genetic testing, faster screening and more precise detection.

The report broadly includes the following:

1. Molecular Diagnostics: An Overview

2. Molecular Diagnostics: Market Analysis
2.1 Market Size and Growth
2.2 Segment Analysis

3. Market Opportunities

4. Growth Drivers

5. Market Trends

6. Competition

7. Company Analysis
7.1 Roche Diagnostics
7.2 Qiagen
7.3 Abbott
7.4 GenProbe

8. Market Outlook
8.1 Market Forecast
8.2 Forecast Methodology
8.2.1 Dependent and Independent Variables
8.2.2 Correlation Analysis
8.2.3 Regression Analysis

List of Figures
Figure 1.1: In Vitro Diagnostic (IVD) Segments
Figure 1.2: Global IVD Market Size – 2006 – 2008 & 2012E
Figure 1.3: IVD Market – Region-wise Breakup (2008)
Figure 1.4: IVD Market – Segment Breakup (2008)
Figure 1.5: Segment-wise Global IVD Market Growth, 2007-2012E
Figure 1.6: CAGR of Global IVD Market segments, 2004-2009E
Figure 2.1: Global Molecular Diagnostics Market Size: 2005 - 2008
Figure 2.2: Molecular Diagnostics Segment Breakup-Value: 2008
Figure 2.3: Molecular Diagnostics Segment Breakup-Percentage: 2008
Figure 3.1: Global HPV market Size (Value): 2003-2008
Figure 3.2: Global HPV market Size (Value) Forecast: 2009-2015
Figure 3.3: Global HPV market Potential by Region
Figure 3.4: Global HPV screening market by region – Penetrated and un-penetrated
Figure 3.5: Cancer: Incidence & Deaths – US (2008)
Figure 3.6: Indian molecular diagnostics market: 2007 - 2009
Figure 4.1: US Cancer Molecular Diagnostics Market: 2006-2012
Figure 4.2: Incidence and mortality – severe sepsis
Figure 4.3: Sales potential of sepsis tests
Figure 5.1: Molecular diagnostics versus traditional tests – Cost comparison
Figure 5.2: Top-10 Molecular Tests - US
Figure 6.1: Market share of leading Players – Global IVD Market: 2008
Figure 6.2: Global Molecular Diagnostics Market Share: Companies - 2008
Figure 6.3: US Molecular Diagnostics Market Share: Companies–2007 vs. 2008
Figure 7.1: Roche Diagnostics – Sales by sub-segment: 2008
Figure 7.2: Qiagen – Sales by product group (2008)
Figure 7.3: Abbott – Sales by business segment (2008)
Figure 7.4: GenProbe – Sales: Clinical Diagnostics & Blood Screening: 2006-08
Figure 8.1: Global Molecular Diagnostics Market Forecast: 2005 - 2010

List of Tables
Table 1.1: IVD market by Technology
Table 8.1 Dependent & Independent Variables (2002 – 2008)
Table 8.2 Correlation Matrix
Table 8.3 Model Summary – Coefficient of Determination
Table 8.4 Regression Coefficients Output.

Agency / Source: Koncept Analytics

Availability: All Regions (Including Int'l)

Traffic Booster: [/] Quick Newswire Today Visibility Checker

Distribution / Indexing: [+]